Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
-
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Flywire Reports Third Quarter 2024 Financial Results
-
ATA Creativity Global Reports Q3 2024 Financial Results
-
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
-
ARKO Corp. Reports Third Quarter 2024 Results
-
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
-
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
-
ACV Announces Third Quarter 2024 Results
-
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
-
Reliance Global Group Reports Third Quarter 2024 Results and Provides Business Update
-
Open Lending Reports Third Quarter 2024 Financial Results
-
Westrock Coffee Company Reports Third Quarter 2024 Results
-
PacBio Announces Third Quarter 2024 Financial Results
-
Safe Bulkers, Inc. Sets Date for the Third Quarter 2024 Results, Conference Call, and Webcast
-
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance
-
The Joint Corp. Reports Third Quarter 2024 Financial Results
-
Jamf Releases Third Quarter 2024 Financial Results
-
LifeMD Reports Third Quarter 2024 Results
-
RCM Technologies, Inc. Announces Third Quarter Results
-
Brilliant Earth Reports Third Quarter 2024 Results
-
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024
-
Synaptics Reports First Quarter Fiscal 2025 Results
-
Phunware Reports Third Quarter 2024 Financial Results
-
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
TELA Bio Reports Third Quarter 2024 Financial Results
-
H&R Block Reports Fiscal 2025 First Quarter Results
-
LifeVantage to Participate at the Sidoti Micro Cap Conference
-
Jushi Holdings Inc. Reports Third Quarter 2024 Financial Results
-
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
-
AvePoint Announces Third Quarter 2024 Financial Results
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
-
Kura Oncology Reports Third Quarter 2024 Financial Results
-
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
-
Jeff’s’ Brands Initiates Strategic Plan by Entering into a Non-Binding Letter of Intent to Sell Subsidiary to a U.S. Public Company at a valuation of approximately $13.125 million
-
Lifetime Brands, Inc. Reports Third Quarter 2024 Financial Results
-
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
-
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
-
RxSight, Inc. Reports Third Quarter 2024 Financial Results
-
CarGurus Announces Third Quarter 2024 Results
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
-
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2025 Financial Results
-
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations
-
AVITA Medical Reports Third Quarter Financial Results
-
PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028
-
Jennifer Lowry to Join the Board of Directors of TPI Composites, Inc.
-
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
